PRIA Logo™
119-hr-10544119th CongressWALLET

Ovarian Cancer IMPACT Act

Sponsored By: Representative DeLauro, Rosa L. [D-CT-3]

Introduced

Summary

This bill would require group health plans and insurers to cover, for eligible enrollees, ovarian cancer genetic counseling and testing. It would also reauthorize and expand Johanna’s Law outreach and boost rural and Tribal access to hereditary cancer care.

Show full summary
  • People at increased hereditary risk would get coverage for counseling, multi-gene panels, germline and somatic tumor testing and named tests such as BRCA1 and BRCA2, Lynch-related markers, mismatch repair deficiency and microsatellite instability, exon rearrangement testing, and genes like BRIP1, RAD51C, and RAD51D. Plans must permit repeat or expanded testing when medically necessary and use the least-restrictive guideline when clinical guidelines conflict.
  • Rural, Tribal, and medically underserved communities would gain expanded Rural Health Care Services Outreach Grants for prevention, diagnosis, treatment, survivorship, genetic risk assessment, counseling, and care coordination. Johanna’s Law activities would be reauthorized and demonstrate projects prioritized for rural or high-risk populations with $20.0 million authorized each year for fiscal years 2027 through 2031.
  • Insurers must apply the new Public Health Service requirements to grandfathered plans and comply for plan years beginning one year after enactment. The bill funds provider education through CDC and HRSA, requires HHS to deliver an implementation plan within 180 days, and mandates periodic reports and evaluations to Congress.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Required coverage for ovarian testing

If enacted, group and individual health plans would have to cover genetic counseling, germline and tumor genomic testing, and medically necessary repeat or expanded testing for people who meet the bill's cancer-history or hereditary-risk criteria. Coverage would include tests for BRCA1/BRCA2, Lynch syndrome markers, BRIP1, RAD51C, RAD51D, and other guideline-recommended panels. Plans must follow the least-restrictive national guideline when guidelines conflict and the rule would apply to grandfathered plans. Coverage would take effect for plan years beginning one year after enactment, and plans may negotiate payment rates with providers.

More outreach, grants, and rural support

If enacted, the bill would reauthorize and expand Johanna's Law outreach and education on ovarian and hereditary cancer syndromes and require culturally and linguistically targeted materials. It would authorize $20,000,000 per year for fiscal years 2027–2031 to support outreach, evaluation, and demonstration projects. The Secretary would run demonstration grants that prioritize rural, underserved, and high-risk communities and report project results annually to Congress. The bill would also expand rural grant and capacity-building authorities to explicitly include ovarian cancer prevention, testing, treatment, survivorship, genetic counseling, and care coordination.

Sponsors & CoSponsors

Sponsor

DeLauro, Rosa L. [D-CT-3]

CT • D

Cosponsors

  • Rep. Balint, Becca [D-VT-At Large]

    VT • D

    Sponsored 10/5/2026

  • Rep. Fitzpatrick, Brian K. [R-PA-1]

    PA • R

    Sponsored 10/5/2026

  • Rep. Bacon, Don [R-NE-2]

    NE • R

    Sponsored 9/24/2026

  • Rep. Vindman, Eugene Simon [D-VA-7]

    VA • D

    Sponsored 10/29/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation